Open competition
Open procedure: the contract was advertised and any supplier could submit a bid.
Key facts
- Buyer
- The NHS Commissioning Board (operating under the name of NHS England) · Ministry or any other national or federal authority, including their regional or local subdivisions
- Supplier
- Shire Pharmaceuticals Ltd
- Value
- £1
- Procedure
- Open procedure
- Sector
- Medical equipment & pharmaceuticals · Blood coagulants (CPV 33141530)
- Region
- North West
- Official notice
- 001672-2021 on Find a Tender
- Timeline
-
- Contract date12 Jan 2021
- Published27 Jan 2021Published 15 days after the contract date
Description
NHS National Framework Agreement for the supply of Recombinant Von Willebrand Factor. The framework will commence on 1 February 2021 for a period of 5 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 43 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.
About the supplier
Shire Pharmaceuticals Ltd: every public contract they have won.